REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/25/2026
Back to search
Official data from USPTO
SEQLL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SEQLL
ST13
US500000086753491Class
1, 5, 9, 42
Filing
86753491
Registration
5251710
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
07/25/2026
Trademark type
Word
Nice classes
1, 5, 9, 42
Filing date
09/10/2015
Registration date
07/25/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/10/2024
Last transaction
07/25/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/23/2013
First use in commerce
07/23/2013
Drawing code
4
Owner type
03
Owner location
Billerica, MA, US
Examiner
HWANG, JOHN C B
Current location
Historical data usage
Holders and representatives
Holders
Seqll, Inc.
Seqll, Inc.
Representatives
Jeffrey Smith Millen-White
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic tests and test kitschipsarraysanalyzers for conducting single molecule sequencing reactionsreactions for the sequencing of DNA and/or RNA for genomic analysis for scientific and research purposes; diagnostic tests and test kitschipsarraysanalyzers for determination of genomic information by sequencing for scientific and research purposes; Assays and reagents for use in genetic research; Test kits for conducting RNA and DNA sequencing for laboratory or research use; Diagnostic tests and test kitschipsarraysanalyzers for conducting single molecule sequencing reactionsreactions for the sequencing of DNA and/or RNA for genomic analysis for clinical or medical laboratory purposes; diagnostic tests and test kitschipsarraysanalyzers for determination of genomic information by sequencing for clinical or medical laboratory purposes
Class 5
Preparations for detecting genetic predispositions for medical purposes; Medical diagnostic reagents and assays that test for detection of genetic traitsgenetic degenerationgenetic diseases and genetic abnormalities
Class 9
Computer software and hardwareoptical detection machinesfor use in DNA and RNA sequencing for genomic analysis and for determination of genomic information by sequencing; Computer software for scientific analysis of genetic sequences; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of genetic traitsgenetic degenerationgenetic diseases and genetic abnormalities for laboratory or research use
Class 42
Product research and development services for others in the field of genomics; medical and scientific research and development services in the field of genomics; Genetic testing for scientific research purposes; Genetic mapping for scientific purposes; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics
Publications
History of USPTO decisions and trademark events.
48 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/10/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/25/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/25/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/21/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/20/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/20/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2017
IUAF
USE AMENDMENT FILED
06/14/2017
EISU
TEAS STATEMENT OF USE RECEIVED
06/14/2017
EX2G
SOU EXTENSION 2 GRANTED
06/14/2017
EXT2
SOU EXTENSION 2 FILED
06/14/2017
EEXT
SOU TEAS EXTENSION RECEIVED
06/14/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/10/2017
EX1G
SOU EXTENSION 1 GRANTED
01/07/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2017
EXT1
SOU EXTENSION 1 FILED
12/14/2016
EEXT
SOU TEAS EXTENSION RECEIVED
12/14/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/14/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/19/2016
PUBO
PUBLISHED FOR OPPOSITION
04/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/30/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/11/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
03/07/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/07/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
03/07/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/07/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/17/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/09/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/23/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/13/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/13/2016
ALIE
ASSIGNED TO LIE
01/13/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/28/2015
GNRT
NON-FINAL ACTION E-MAILED
12/28/2015
CNRT
NON-FINAL ACTION WRITTEN
12/28/2015
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/28/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/28/2015
DOCK
ASSIGNED TO EXAMINER
12/22/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
09/17/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2015
NWAP
NEW APPLICATION ENTERED
09/14/2015
Continuous trademark protection
Get notified about every new filing that threatens SEQLL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.